Is the World Running Out of Oil? Goldman Sachs Weighs In
Goldman Sachs analysis says the world is not running out of oil despite the Middle East conflict disrupting the Strait of Hormuz. Asian economies that source roughly half of their fuel from the Gulf are feeling strain as shipments fall, prompting reliance on inventories and alternative suppliers. Petrochemical feedstocks such as naphtha and LPG are already tight, while diesel and jet‑fuel prices have surged globally. The bank warns that temporary buffers could erode if the disruption persists, risking localized shortages and price spikes.
Saudi Arabia’s Non-Oil Business Activity Shrinks in March Amid Conflict, PMI Shows
Saudi Arabia’s non‑oil private‑sector activity contracted in March, with the Riyad Bank PMI slipping to 48.8 from 56.1 in February. The decline marks the first contraction since August 2020 and reflects heightened geopolitical risk from the regional conflict. New‑orders and...
War Weighs on Egypt’s Private Sector as PMI Hits Near Two-Year Low in March
Egypt’s non‑oil private sector contracted sharply in March, with the S&P Global PMI slipping to 48.0, its lowest level since April 2024. Output and new orders fell to near‑two‑year lows, while firms blamed the Middle East conflict for weakened demand...
Can the Energy Price Shock Push the UK Into Recession?
Deutsche Bank warns that a massive global energy price shock could push the United Kingdom into recession, slashing its GDP growth forecast to a narrow 0.35‑0.7% range. The analysis highlights a “non‑linear” risk where growth could contract faster than traditional...
Climb Bio Announces Departure of Finance SVP and Appointment of New Accounting Officer
Climb Bio announced that Senior Vice President of Finance Cindy Driscoll will depart on April 30, 2026, and that Chief Financial Officer Dr. Susan Altschuller will assume the principal accounting officer role. The biotech firm, valued at roughly $313 million, has...
Roth/MKM Downgrades Apellis Stock Rating on Biogen Acquisition
Roth/MKM downgraded Apellis Pharmaceuticals to Neutral from Buy and lifted its price target to $41, matching Biogen’s cash offer of $41 per share. The acquisition values Apellis at roughly $5.6 billion, an 86% premium to its recent average price, and is...
JPMorgan Downgrades Bank of the Philippine Islands Stock Rating
JPMorgan downgraded Bank of the Philippine Islands (BPI) to Neutral from Overweight and cut its price target to PHP 105 (≈ $1.9) from PHP 145 (≈ $2.6). The stock has slipped 23% over the past year and is down 13% year‑to‑date. The downgrade reflects...
JPMorgan Upgrades Chagee Holdings Stock Rating on Sales Recovery
JPMorgan upgraded Chagee Holdings (NASDAQ: CHA) to Overweight, lifting its price target to $16 from $11.50. The move reflects a slowdown in same‑store sales declines, with Q1 2026 domestic same‑store sales falling only in the teens versus a 25.5% drop...
Swiss Inflation Hits One-Year High as Fuel Prices Rise
Swiss inflation rose to 0.3% in March, the highest level in a year, driven primarily by a 5.3% jump in petroleum product prices amid Middle‑East tensions. The increase was modest, falling short of the 0.5% forecast and the 0.2% month‑on‑month...
Baird Cuts Akamai Stock Rating on Valuation After 33% Rally
Akamai Technologies' stock has surged 33% year‑to‑date, prompting Baird to downgrade its rating from Outperform to Neutral and set a new price target of $110. The firm cites the recent rally—driven by optimism around AI, compute, and agentic traffic—as unsustainable...
Fairmount Funds Sells Cogent Biosciences (COGT) Shares for $242.6m
Fairmount Funds Management LLC sold 7 million Cogent Biosciences shares for $242.6 million on March 31, 2026, at $34.66 per share. The stock subsequently climbed to $38.49, reflecting a 565% return over the past year and a 172% gain in the last six...
Trading Day: Growth Fears Snowball
Oil prices rose sharply as Brent crude briefly touched $115 per barrel after former President Donald Trump warned of potential attacks on Iranian energy infrastructure. Gold edged higher, buoyed by dip‑buying and reassuring comments from Fed Chair Jerome Powell. U.S....
Jefferies Initiates Vor Biopharma Stock with Buy Rating on Autoimmune Pivot
Jefferies has initiated coverage of Vor Biopharma with a buy rating and a $50 price target, far above the current $14.48 share price. The company recently pivoted to autoimmune diseases, licensing telitacicept for lupus, rheumatoid arthritis, and myasthenia gravis, and...
JPMorgan Upgrades HDFC Bank Stock Rating on Valuation Appeal
JPMorgan upgraded HDFC Bank to Overweight, lowering its price target to INR 1,010 (about $12.2). The bank’s shares have fallen 33% YTD, trading at a 16‑year low price‑to‑book of 1.5× and a $24.35 price near its 52‑week low. The rating lift...
WTO at ’Critical Juncture’ and Needs Deep Reform, EU and CPTPP Say
The European Union and the 12‑nation CPTPP bloc issued a joint statement at the WTO ministerial in Yaoundé, calling the organization’s future a "critical juncture" that demands urgent, deep, and inclusive reform. Both groups highlighted concerns over market‑distorting practices, oversupply,...
US Consumer Sentiment Slips to a Three-Month Low in March
U.S. consumer sentiment fell to a three‑month low in March, with the University of Michigan’s index slipping to 53.3, the weakest reading since December. The decline was driven by a sharp rise in oil prices—up more than 30% after the...
Paranovus Entertainment to Execute 1-for-12 Reverse Stock Split
Paranovus Entertainment Technology Ltd (NASDAQ:PAVS) will implement a 1‑for‑12 reverse stock split on March 31, 2026, reducing its outstanding Class A shares from about 11.3 million to roughly 945 k. The split aims to lift the share price from its current $0.21 level,...
Celldex Reports Quality of Life Gains in Urticaria Trials
Celldex Therapeutics reported Phase 2 data showing its KIT‑targeting antibody barzolvolimab dramatically improves quality‑of‑life scores for chronic spontaneous urticaria (CSU) and chronic inducible urticaria (CIndU). At Week 52, 94 % of CSU patients achieved a Dermatology Life Quality Index (DLQI) of 0‑1, and...
William Blair Reiterates Outperform on ARS Pharma Stock After FDA Label Update
William Blair reaffirmed an Outperform rating on ARS Pharmaceuticals (NASDAQ: SPRY) after the FDA removed an age restriction for neffy patients weighing 33‑66 lb, opening the drug to roughly 25% of current epinephrine prescriptions. The firm highlighted the label change as...
Retired U.S. Admiral Warns Iran War Could Last Longer than Expected
Retired Vice Admiral Colin Kilrain warned that the U.S. war with Iran could extend far beyond the four‑to‑six‑week window President Donald Trump initially envisioned. He noted the conflict’s roots in decades‑long U.S.–Iran tensions and the lack of diplomatic ties since...
Earnings Call Transcript: Racing Force Group Reports Strong H2 2025 Growth
Racing Force Group posted robust 2025 results, with revenue climbing 11.4% to €73.1 million (≈ $79.7 million) and gross margin expanding to 63.3%. Adjusted EBITDA surged 21.2% to €12.8 million (≈ $13.9 million), driven by a 20% sales acceleration in the second half, especially from newly...
Cuban Doctors Endure Burnout, Blackouts as Once-Vaunted Healthcare Declines
Cuban doctors, earning roughly $16 a month, are forced to take side jobs to survive. The public health system faces severe shortages, with a surgery waiting list projected to swell to 160,000 by year‑end and over 300 pediatric operations each...
Israel Strikes Tehran as Trump Says US Negotiating to End War
Israel launched a missile strike on Tehran while President Trump announced that the United States is negotiating a cease‑fire with Iran. The news sent crude oil prices plunging more than 6%, before partially recovering on doubts about the report’s veracity....
White House Eyes Iran’s Parliament Speaker Ghalibaf as Potential US-Backed Leader, Politico Reports
The White House is reportedly positioning Iran’s parliament speaker, Mohammad‑Reza Ghalibaf, as a potential US‑backed leader, signaling a possible diplomatic pivot. President Trump has postponed planned strikes on Iranian power plants, describing recent talks with Tehran as “very good.” The...
Israel Strikes Main Bridge in South Lebanon, Orders Destruction of Homes Near Border
Israel’s defence minister ordered the destruction of all bridges over Lebanon’s Litani River and accelerated demolition of homes in border villages after an Israeli civilian was killed in a cross‑border attack. The move expands a bombing campaign that has already...
Nikkei 225 and TOPIX: Already Bottomed or Further Downside Ahead?
Bank of America sees the recent Nikkei 225 and TOPIX sell‑off as potentially marking a short‑term floor, but the market’s trajectory remains tied to geopolitical developments, especially the Middle East conflict and energy price stability. The decline was intensified by...
Exclusive-Bahrain Cites Patriot Interception in March 9 Iranian Drone Incident
Bahrain announced that its Patriot air‑defence system intercepted an Iranian drone over the Sitra district on March 9, preventing a direct hit on a residential area. The drone strike initially injured 32 civilians, including children, and was previously described by the...
Earnings Call Transcript: Fraport AG Q4 2025 Sees Record EBITDA, Stock Rises
Fraport AG reported a record fourth‑quarter 2025 EBITDA, driving its shares higher in early trading. The airport operator highlighted a strong rebound in passenger volumes and higher ancillary revenues from retail and parking. Management signaled continued investment in digital services...
Active Dynamics Buys First Brands’ Walbro Business for $50 Million
Active Dynamics announced the acquisition of First Brands' Walbro business for $50 million. Walbro, a specialist in high‑performance fuel‑system components, will become part of Active Dynamics' aftermarket portfolio. The deal broadens the company's product range and strengthens its foothold in...
Better Collective Posts Record EBITDA Amid Revenue Headwinds
Better Collective reported Q4 2025 revenue of €94.3 million, a 2% YoY decline but flat in constant currencies, while achieving a record quarterly EBITDA before special items of €37 million (39% margin), beating consensus. Full‑year revenue fell 9% to €337 million and EBITDA...
UBS Raises Dana Holding Stock Price Target on Margin Outlook
UBS upgraded its outlook on Dana Holding Corp., raising the 12‑month price target after a stronger‑than‑expected margin outlook. The Swiss bank lifted the target to $12.00 from $9.00, implying roughly 33% upside from the current share price. UBS highlighted improved...
UBS Raises Carter’s Stock Price Target to $40 on Improved Fundamentals
Earnings Call Transcript: Deere & Company Q1 2026 Sees Strong Earnings Beat
Deere & Company posted a Q1 2026 earnings surprise, reporting EPS of $2.42 versus the $2.02 consensus and revenue of $9.61 billion, well above the $7.59 billion forecast. The equipment operations segment drove growth, delivering an 18% jump in net sales to $8.0 billion....
Materion Director Khilnani Sells $595k in Stock
Earnings Call Transcript: Nutrien Q4 2025 Misses Forecasts, Stock Dips
Nutrien Ltd. reported Q4 2025 earnings that fell short of forecasts, posting EPS of $0.83 versus the expected $0.92 and revenue of $5.34 billion against a $5.38 billion outlook. The miss triggered a 0.87% pre‑market decline in the stock despite a 13% rise...
SolarEdge Faces Earnings Test as Inverter Market Softens
